Now showing items 1-3 of 3

    • Gemcitabine integrated nano-prodrug carrier system 

      Hamsici, S.; Ekiz, M. S.; Ciftci, G. C.; Tekinay, A. B.; Guler, M. O. (American Chemical Society, 2017)
      Peptide nanomaterials have received a great deal of interest in drug-delivery applications due to their biodegradability, biocompatibility, suitability for large-scale synthesis, high drug-loading capacities, targeting ...
    • Injectable in situ forming microparticles: A novel drug delivery system 

      Yapar, E. A.; Inal, Ö.; Özkan, Y.; Baykara, T. (2012)
      Pharmaceutical formulation research has recently been focusing on delivery systems which provide long therapeutic effects and reduced side effects, and involving simplified production stages and facilitated application ...
    • Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells 

      Kahraman, D. C.; Hanquet, G.; Jeanmart, L.; Lanners, S.; Šramel, P.; Boháč, A.; Cetin-Atalay, R. (Royal Society of Chemistry, 2017)
      Bioactivities of quinoides 1–5 and VEGFR2 TKIs 6–10 in hepatocellular cancer (HCC) and cancer stem cells (HCSCs) were studied. The compounds exhibited IC50 values in μM concentrations in HCC cells. Quinoide 3 was able to ...